Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal <i>CRTAM</i> and <i>PLCB1</i> as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn's Disease.

Pharmaceutics · 2024 · PMC11207411 · PMID 38931955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

For that, publicly available summary statistics of nominally significant variants with ADA immunogenicity in 96 Spanish Caucasian European CD patients were used [ 75 ].

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.